Diana Zatreanu, Postdoctoral research fellow
The best thing about working at the ICR is the close-knit family feeling, which improves collaborations and scientific discoveries.
ICR welcomes approval for new ovarian cancer drug combination
The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA).
New weakness to target breast cancer cells discovered
Researchers at The Institute of Cancer Research, London, have uncovered a hidden weakness in some breast cancer tumours that could lead to smarter treatment decisions.